Dementia in Morbus Parkinson: Reasonable diagnostics and rational therapy;Demenz bei Morbus Parkinson: Sinnvolle Diagnostik und rationale Therapie

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 9, 2010, Pages 513-518

  Timmermann, L ^a   Maier, F ^a   Eggers, C ^a   Schmidt, M ^a   Kalbe, E ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF VECHTA   (Germany)

Author keywords

acetylcholine esterase inhibitors; cognitive decline; dementia; neuropsychology; Parkinsons disease

Indexed keywords

CHOLINESTERASE INHIBITOR; CLOZAPINE; DONEPEZIL; FLUORODEOXYGLUCOSE; GALANTAMINE; QUETIAPINE; RIVASTIGMINE;

ALZHEIMER DISEASE; ATTENTION; CAREGIVER; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; HUMAN; NEUROPSYCHOLOGICAL TEST; NURSING HOME; PARKINSON DISEASE; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUALITY OF LIFE; REVIEW;

AGED; ATTENTION; CAREGIVERS; COGNITION; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; EXECUTIVE FUNCTION; HUMANS; LEWY BODY DISEASE; MENTAL RECALL; PARKINSON DISEASE; SPACE PERCEPTION; VISUAL PERCEPTION;

EID: 77956666511     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245644     Document Type: Review

References (25)

1. Parkinson J. An Essay on the Shaking Palsy. Sherwood, Neely, and Jones 66. London 1817
2. Braak H, Braak E. Pathoanatomy of Parkinsons disease. J Neurol 2000 247 (Suppl 2) II3-II10
3. Braak H et al. Staging of brain pathology related to sporadic Parkinsons disease. Neurobiol Aging 2003 24 (2) 197-211
4. Braak H et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005 64 (8) 1404-1410
5. Aarsland D et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003 60 (3) 387-392
6. Riedel O et al. Cognitive impairment in 873 patients with idiopathic Parkinsons disease. Results from the German Study on Epidemiology of Parkinsons Disease with Dementia (GEPAD). J Neurol 2008 255 (2) 255-264
7. Levy G et al. Memory and executive function impairment predict dementia in Parkinsons disease. Mov Disord 2002 17 (6) 1221-1226
8. Levy G et al. Combined effect of age and severity on the risk of dementia in Parkinsons disease. Ann Neurol 2002 51 (6) 722-729
9. Aarsland D et al. Neuropsychiatric symptoms in patients with Parkinsons disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007 78 (1) 36-42
10. Klepac N et al. Is quality of life in non-demented Parkinsons disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol 2008 15 (2) 128-133
11. Schrag A et al. Caregiver-burden in parkinsons disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 2006 12 (1) 35-41
12. Nussbaum M et al. Survival in Parkinsons disease: the effect of dementia. Parkinsonism Relat Disord 1998 4 (4) 179-181
13. Bosboom J L., Stoffers D, Wolters E. Cognitive dysfunction and dementia in Parkinsons disease. J Neural Transm 2004 111 (10 11) 1303-1315
14. Aarsland D et al. Predictors of nursing home placement in Parkinsons disease: a population-based, prospective study. J Am Geriatr Soc 2000 48 (8) 938-942
15. Findley L et al. Direct economic impact of Parkinsons disease: a research survey in the United Kingdom. Mov Disord 2003 18 (10) 1139-1145
16. Förstl H et al. Diagnostik degenerativer Demenzen (M. Alzheimer, frontotemporale-, Lewy-Körperchen-Demenz). in Diener H C. Putzki N Editors Leitlinien für die Diagnostik und Therapie in der Neurologie,. Stuttgart Thieme 2008
17. Schmidtke K, Hermeneit S. High rate of conversion to Alzheimers disease in a cohort of amnestic MCI patients. Int Psychogeriatr 2008 20 (1) 96-108
18. Candy J M. et al. Pathological changes in the nucleus of Meynert in Alzheimers and Parkinsons diseases. J Neurol Sci 1983 59 (2) 277-289
19. Perry R H. et al. Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet 1983 2 (8353) 789-790
20. Emre M et al. Clinical diagnostic criteria for dementia associated with Parkinsons disease. Mov Disord 2007 22 (12) 1689-1707; quiz 1837
21. McKeith I G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005 65 (12) 1863-1872
22. Kalbe E et al. Screening for cognitive deficits in Parkinsons disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 2008 14 (2) 93-101
23. Menza M et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009 72 (10) 886-892
24. Emre M et al. Rivastigmine for dementia associated with Parkinsons disease. N Engl J Med 2004 351 (24) 2509-2518
25. Poewe W. Treatment of dementia with Lewy bodies and Parkinsons disease dementia. Mov Disord 2005 20 (Suppl 12) S77-S82